Sesamol attenuate 3-nitropropionic acid-induced huntington-like behavioral, biochemical, and cellular alterations in rats

Journal of Asian Natural Products Research

Volumn 11, Issue 5, 2009, Pages 439-450

  Kumar, Puneet ^a   Kalonia, Harikesh ^a   Kumar, Anil ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

3 nitropropionic acid; Huntington's disease; Mitochondrial dysfunction; Oxidative stress; Sesamol

Indexed keywords

3 NITROPROPIONIC ACID; CATALASE; MITOCHONDRIAL ENZYME; NITRITE; SESAME SEED OIL; SESAMOL; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG; 1,3 BENZODIOXOLE DERIVATIVE; 3-NITROPROPIONIC ACID; NITRO DERIVATIVE; PHENOL DERIVATIVE; PROPIONIC ACID DERIVATIVE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; BRAIN CORTEX; CONTROLLED STUDY; CORPUS STRIATUM; DRUG DOSE COMPARISON; HIPPOCAMPUS; HUNTINGTON CHOREA; LIPID PEROXIDATION; LOCOMOTION; MALE; MOTOR COORDINATION; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; RAT; ANIMAL; BRAIN; CHEMICAL STRUCTURE; CHEMICALLY INDUCED DISORDER; CHEMISTRY; DRUG EFFECT; MEDICINAL PLANT; METABOLISM; SESAME; SPRAGUE DAWLEY RAT;

ANIMALIA; PEDALIACEAE; RATTUS; SESAMUM INDICUM;

ANIMALS; BEHAVIOR, ANIMAL; BENZODIOXOLES; BRAIN; HUNTINGTON DISEASE; MALE; MOLECULAR STRUCTURE; NITRO COMPOUNDS; PHENOLS; PLANTS, MEDICINAL; PROPIONIC ACIDS; RATS; RATS, SPRAGUE-DAWLEY; SESAMUM;

EID: 67149091104     PISSN: 10286020     EISSN: 14772213     Source Type: Journal    
DOI: 10.1080/10286020902862194     Document Type: Article

References (30)

1. A.A. Fatokun, T.W. Stone, and R.A. Smith, Front Biosci. 13, 3288 (2008).
2. H. Fukui and C.T. Moraes, Trends Neurosci. 31, 251 (2008).
3. M.F. Beal, Ann. Neurol. 58, 495 (2005).
4. T.K. Koutouzis, C.V. Borlongan, T. Scorcia, I. Creese, D.W. Cahill, T.B. Freeman, and P.R. Sanberg, Brain Res. 646, 242 (1994).
5. A. Ahmad, F.A. Syed, S. Singh, and S.M. Hadi, Toxicol. Lett. 159, 1 (2005).
6. R.C. Hou, Y.S. Chen, C.H. Chen, Y.H. Chen, and K.C. Jeng, J. Biomed. Sci. 13, 89 (2006).
7. S.J. Tabrizi, M.W. Cleeter, J. Xuereb, J.W. Taanman, J.M. Cooper, and A.H. Schapira, Ann. Neurol. 45, 25 (1999).
8. A. Kuhad and K. Chopra, Exp. Brain Res. 185, 411 (2008).
9. A. Hagiwara, Y. Kokubo, Y. Takesada, H. Tanaka, S. Tamano, M. Hirose, T. Shirai, and N. Ito, Teratog. Carcinog. Mutagen. 16, 317 (1996).
10. J.B. Schulz, D.R. Henshaw, U. MacGar-vey, and M.F. Beal, Neurochem. Int. 29, 167 (1996).
11. B.S. Mandavilli, I. Boldogh, and B. Van Houten, Brain Res. Mol. Brain Res. 133, 215 (2005).
12. T. Osawa, H. Kumon, M. Namiki, S. Kawakishi, and Y. Fukuda, Prog. Clin. Biol. Res. 342, 223 (1990).
13. R.C. Hou, H.L. Chen, J.T. Tzen, and K.C. Jeng, Neuroreport 14, 1815 (2003).
14. D.Z. Hsu, S.P. Chien, K.T. Chen, and M.Y. Liu, Shock 28, 596 (2007).
15. R. Joshi, M.S. Kumar, K. Satyamoorthy, M.K. Unnikrisnan, and T. Mukherjee, J. Agric. Food Chem. 53, 2696 (2005).
16. K. Akimoto, Y. Kitagawa, T. Akamatsu, N. Hirose, M. Sugano, S. Shimizu, and H. Yamada, Ann. Nutr. Metab. 37, 218 (1993).
17. S.E. Browne, R.J. Ferrante, and M.F. Beal, Brain Pathol. 9, 147 (1999).
18. P. Kumar, S.S. Padi, P.S. Naidu, and A. Kumar, Meth. Find. Exp. Clin. Pharmacol. 29, 1 (2007).
19. P. Kumar, S.S. Padi, P.S. Naidu, and A. Kumar, Behav. Pharmacol. 17, 485 (2006).
20. P. Kumar and A. Kumar, Prog. Neuropsychopharmacol. Biol. Psychiatry 33, 100 (2009).
21. E.D. Wills, Biochem. J. 99, 667 (1966).
22. L.C. Green and S.R. Tannebaum, Ann. Biochem. 126, 131 (1982).
23. H. Luck, Catalase, in Methods of Enzymatic Analysis, edited by H.U. Bergmeyer (Academic Press, New York, 1971), Vol. 3, p. 885.
24. Y. Kono, Arch. Biochem. Biophys. 186, 189 (1978).
25. A.G. Gornall, J. Biol. Chem. 177, 751 (1949).
26. S.B. Berman and T.G. Hastings, J. Neurochem. 73, 1127 (1999).
27. T.E. King and R.L. Howard, Meth. Enzymol. 10, 275 (1967).
28. T.E. King, Meth. Enzymol. 10, 322 (1967).
29. G.L. Sottocasa, B. Kuylenstierna, L. Ernster, and A. Bergstrand, J. Cell. Biol. 32, 415 (1967).
30. Y. Liu, D.A. Peterson, H. Kimura, and D. Schubert, J. Neurochem. 69, 581 (1997).